These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9768727)

  • 1. Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease.
    Denney WD; Kemp WE; Anthony LB; Oates JA; Byrd BF
    J Am Coll Cardiol; 1998 Oct; 32(4):1017-22. PubMed ID: 9768727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with progression of carcinoid heart disease.
    Møller JE; Connolly HM; Rubin J; Seward JB; Modesto K; Pellikka PA
    N Engl J Med; 2003 Mar; 348(11):1005-15. PubMed ID: 12637610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic follow-up of treated patients with carcinoid syndrome.
    Mansencal N; Mitry E; Bachet JB; Rougier P; Dubourg O
    Am J Cardiol; 2010 Jun; 105(11):1588-91. PubMed ID: 20494667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
    Pellikka PA; Tajik AJ; Khandheria BK; Seward JB; Callahan JA; Pitot HC; Kvols LK
    Circulation; 1993 Apr; 87(4):1188-96. PubMed ID: 7681733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for the development and progression of carcinoid heart disease.
    Bhattacharyya S; Toumpanakis C; Chilkunda D; Caplin ME; Davar J
    Am J Cardiol; 2011 Apr; 107(8):1221-6. PubMed ID: 21296329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic diagnosis in carcinoid heart disease.
    Wonnink-De JW; Knibbeler-Van RC; Van der Heul C; Pasteuning WH
    Neth J Med; 2002 May; 60(4):181-5. PubMed ID: 12164398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of Contemporary Valve Surgery in Patients with Carcinoid Heart Disease.
    Kuntze T; Owais T; Secknus MA; Kaemmerer D; Baum R; Girdauskas E
    J Heart Valve Dis; 2016 May; 25(3):356-363. PubMed ID: 27989047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of 3D transoesophageal echocardiography for the assessment of tricuspid and pulmonary valves in carcinoid heart disease.
    Bhattacharyya S; Burke M; Caplin ME; Davar J
    Eur J Echocardiogr; 2011 Jan; 12(1):E4. PubMed ID: 20729293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality.
    Dobson R; Burgess MI; Valle JW; Pritchard DM; Vora J; Wong C; Chadwick C; Keevi B; Adaway J; Hofmann U; Poston GJ; Cuthbertson DJ
    Br J Cancer; 2014 Oct; 111(9):1703-9. PubMed ID: 25211656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 33-year follow-up after valvular surgery for carcinoid heart disease.
    Bergsten J; Flachskampf FA; Lundin L; Öhagen P; Albåge A
    Eur Heart J Cardiovasc Imaging; 2022 Mar; 23(4):524-531. PubMed ID: 33899077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoid Heart Disease: Prognostic Value of 5-Hydroxyindoleacetic Acid Levels and Impact on Survival: A Systematic Literature Review.
    Buchanan-Hughes A; Pashley A; Feuilly M; Marteau F; Pritchard DM; Singh S
    Neuroendocrinology; 2021; 111(1-2):1-15. PubMed ID: 32097914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease.
    Dobson R; Cuthbertson DJ; Jones J; Valle JW; Keevil B; Chadwick C; Poston GP; Burgess MI
    Neuroendocrinology; 2014; 99(2):85-93. PubMed ID: 24603343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tricuspid valve in carcinoid syndrome. An echocardiographic study.
    Taber M; Askenazi J; Ribner H; Kumar S; Lesch M
    Arch Intern Med; 1983 May; 143(5):1033-4. PubMed ID: 6206810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do indole markers predict carcinoid heart disease?
    Arora RR; Warner RR
    Chest; 1986 Jul; 90(1):87-9. PubMed ID: 2424676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease.
    Himelman RB; Schiller NB
    Am J Cardiol; 1989 Feb; 63(5):347-52. PubMed ID: 2464278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography.
    Robiolio PA; Rigolin VH; Wilson JS; Harrison JK; Sanders LL; Bashore TM; Feldman JM
    Circulation; 1995 Aug; 92(4):790-5. PubMed ID: 7641358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of Carcinoid Heart Disease in the Modern Management Era.
    Baron E; Szymanski C; Hergault H; Lepère C; Dubourg O; Hauguel-Moreau M; Mansencal N
    J Am Heart Assoc; 2021 Dec; 10(23):e020475. PubMed ID: 34816734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoid heart disease.
    van der Horst-Schrivers AN; Wymenga AN; de Vries EG
    N Engl J Med; 2003 Jun; 348(23):2359-61; author reply 2359-61. PubMed ID: 12789004
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinoid heart disease: typical findings on echocardiography and cardiac magnetic resonance.
    Moerman VM; Dewilde D; Hermans K
    Acta Cardiol; 2012 Apr; 67(2):245-8. PubMed ID: 22641985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI.
    Bhattacharyya S; Toumpanakis C; Burke M; Taylor AM; Caplin ME; Davar J
    Circ Cardiovasc Imaging; 2010 Jan; 3(1):103-11. PubMed ID: 19920029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.